3D printed artificial ovarium biological stent capable of activating original ovarian follicle and artificial ovarium and application thereof
A primordial follicle and biological scaffold technology, applied in the field of 3D printing biological scaffold preparation, can solve the problems of irreplaceable effects, hormone therapy is not suitable for everyone, difficult to give doses, etc., to achieve rich nutrient supply, shorten activation time, reduce The effect of waiting time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0055] Example 1 Design and preparation of 3D printed bioscaffold
[0056] (1) Combined with computer aided design (CAD), three-dimensional printing technology is used to construct biological scaffolds. The shape of 3D biological scaffolds is selected as circular, rectangular, square, elliptical or irregular, and the internal structure is connected. Pore; pore size (R): 400μm; line stacking angle: 30-120 degrees;
[0057] (2) Prepare 3D printing bio-scaffold printing materials, which include a mixture of biocompatible materials, primordial follicle activators, and primordial follicle development promoters; the biocompatible materials are 3%-5% sodium alginate and 8%- 10% gelatin, the mass ratio of sodium alginate and gelatin is 1:1, it becomes gelatinous at room temperature after mixing. Add 740Y-P 10ug / ml, PA 8uM, PRO 2uM, FSH 100mIU, LH 10mIU, EGF 5ng / ml, ITS (used after 100-fold dilution) to the biocompatible material.
[0058] (3) Print the ovarian stent by 3D printing; ...
Embodiment 2
[0060] Example 2 Design and preparation of 3D printed bioscaffold
[0061] The scaffold prepared in Example 2 is the same as that in Example 1, except for the formulation of the printing material in step (2), which is formulated according to the proportions listed in the table below.
[0062]
[0063]
[0064] Example 2 Obtaining of primordial follicles
[0065] The 3-day-old female mice were killed by cervical dislocation, and after the skin was disinfected, the ovaries were aseptically removed from the dorsal position, and put into the separation medium (L-15+10%FBS+100IU / ml penicillin+100ug / ml chain mycin). The accompanying tissues around the ovaries were removed under a solid microscope, and washed 3 times in the separation solution. Then the ovary was needled with insulin metered injection under the microscope, and the mouse ovary was divided into tissue fragments containing primordial follicles.
Embodiment 3
[0066] Example 3 Activation of primordial follicles
[0067] The activator is an agonist or inhibitor of a signaling pathway related to primordial follicle activation, which belongs to the prior art and can be purchased from the market.
[0068] The cryopreserved or fresh ovarian cortex containing a large number of primordial follicles was minced, incubated and activated in basal culture medium containing different combinations of follicle activators for 0.5 to 6 hours, washed with normal saline three times to remove foreign substances, and then moved into the printing A good bioscaffold was transplanted under the kidney capsule of an adult female rat with bilateral ovariectomy.
[0069] Wherein the basal culture solution formula of the follicle activator is:
[0070]
[0071]
PUM
Property | Measurement | Unit |
---|---|---|
Pore size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com